Yamini Maddala is a Gastroenterology physician. OpenAlex indexes 5 publications with 218 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
981 State Highway 121
Suite 1140
Allen, TX 75013
Telephone
469-697-5100Provider last certified this registry record 2 Sept 2020.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202511 payments
- Janssen Biotech, Inc.Program year20257 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
98.1%Proton pump inhibitor66%Pantoprazole Sodium77%Esomeprazole Magnesium13%Omeprazole7%Lansoprazole3%Part D<11 patientsAluminum Complex20.6%Sucralfate100%Part D≥52 patients+ 3 more classes in this area
Sensory organs
1.9%Corticosteroid1.9%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Open-Label Pilot Study of Tetracycline in the Treatment of Primary Biliary Cirrhosis
The American Journal of Gastroenterology
2004 - ENDOSCOPIC BIOPSY NEGATIVE ESOPHAGEAL METASTASIS DIAGNOSIS BY ENDOSCOPIC ULTRASOUND
The American Journal of Gastroenterology
2004 - USE OF INFLIXIMAB, PEGYLATED INTERFERON AND RIBAVIRIN IN A PATIENT WITH CROHNʼS DISEASE AND HEPATITIS C INFECTION
The American Journal of Gastroenterology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”